Baxter
BAX
#1124
Rank
NZ$29.60 B
Marketcap
$57.99
Share price
0.18%
Change (1 day)
-9.59%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - Net assets

Net assets on the balance sheet as of September 2024 : NZ$14.06 Billion

According to Baxter's latest financial reports the company has NZ$14.06 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Baxter - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$13.39 B44.21%
2022-12-31$NZ$9.28 B-30.47%
2021-12-31$NZ$13.35 B10.42%
2020-12-31$NZ$12.09 B2.94%
2019-12-31$NZ$11.74 B0.18%
2018-12-31$NZ$11.72 B-8.64%
2017-12-31$NZ$12.83 B7.38%
2016-12-31$NZ$11.95 B-7.71%
2015-12-31$NZ$12.95 B24.43%
2014-12-31$NZ$10.40 B0.8%
2013-12-31$NZ$10.32 B21.74%
2012-12-31$NZ$8.48 B-3.04%
2011-12-31$NZ$8.74 B-0.68%
2010-12-31$NZ$8.80 B-13.77%
2009-12-31$NZ$10.21 B-4.83%
2008-12-31$NZ$10.73 B18.88%
2007-12-31$NZ$9.02 B1.42%
2006-12-31$NZ$8.90 B41.55%
2005-12-31$NZ$6.28 B21.13%
2004-12-31$NZ$5.19 B3.09%
2003-12-31$NZ$5.03 B-10.31%
2002-12-31$NZ$5.61 B-37.93%
2001-12-31$NZ$9.04 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
-NZ$5.81 Billion-141.25%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$35.67 B 153.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$37.10 B 163.86%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$45.83 B 225.98%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.80 B-94.30%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$86.93 B 518.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.54 B-88.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$86.25 B 513.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$3.62 B-74.21%๐Ÿ‡บ๐Ÿ‡ธ USA